Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the results of resolutions presented at its Combined General Meeting, held on December 20, 2023 and made them available on the dedicated section of its website.
